Monal Therapeutics is a development stage biotechnology company company dedicated exclusively to the treatment and cure of cancer. After more than 40 years of tireless research, we have develop advanced therapeutic solutions based on cutting-edge science that act directly on the mechanisms that keep cancer active and growing.

Our platform of effective and well-tolerated drugs focuses on the precise cellular interactions, avoiding the accumulation of unadministered drug residues, which often cause unwanted side effects. Our novel approach to cancer treatment has virtually eliminated side effects and will significantly improve the quality of life of patients.

We believe that the future of medicine lies in the combination of technologies, international collaboration, and a strong commitment to human health and well-being. Our goal is to push the boundaries of oncology and bring to market treatments that not only fight cancer but do so intelligently and responsibly.